"We Envision Growth Strategies Most Suited
to Your Business"
The global polymerase chain reaction (PCR) market size is anticipated to reach USD 8.14 billion by 2026, attributable to the increasing prevalence of chronic and infectious diseases such as tuberculosis, cancer, and others worldwide. PCR is a process utilized in molecular biology to produce a million copies from a single DNA sample. This allows scientists and forensic researchers to solve crime cases even in age-old samples such as mummies. More information on this market is presented in a recently published report by Fortune Business Insights™ titled, “Polymerase Chain Reaction (PCR) Market Size, Share & Industry Analysis, By Type (Standard PCR, Real-time PCR, and Digital PCR), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026.” As per this report, the market was USD 4.31 billion in 2018 and is likely to exhibit a CAGR of 8.3 % during 2019 and 2026.
CFX Maestro Software launched by Bio-Rad will Help Set up and Run PCR Experiments Effortlessly
June 2017 witnessed the launch of CFX Maestro Software produced by Bio=Rad Laboratories Inc., for CFX Real-time instruments providing complete workflow solution for PCR data analysis and collection. This will help scientists conduct data analysis with the help of tools such as data visualization, normalization, supporting gene selection, and efficiency-corrected relative normalization. The global product manager of Bio-Rad, Aaron Burke, said, “The major objective of the company is to provide software that eases the pain of real-time PCR starting from the plate setup to publication and throughout the data analysis. The company also introduced a Mac version to the software for easy analysis on a PC or Mac.” Such efforts are likely to bode well for the market and improve the market position of companies in the coming years.
To get a detailed report summary and research scope of this market, click here:
Increasing Demand for Miniature PCR Devices will Augment Growth
The increasing prevalence of genetic and infectious diseases is a significant polymerase chain reaction market growth driver. Besides this, the growing number of tuberculosis and cancer cases in developing nations is also fueling the demand for PCR devices. Moreover, current PCR market trend of adopting digital PCR than real-time PCR is expected to augment growth. However, factors such as high cost of commercial PCR assays may pose a significant threat to the overall polymerase chain reaction market growth in the forecast period. Besides this, companies are making relentless efforts to introduce miniature PCR devices and this will also help the market gain impetus in the coming years. Nevertheless, both non-government and government organizations are spreading awareness about the availability of PCR devices for diagnostic purposes and such initiatives will create lucrative growth opportunities for the market in the long run.
Players are Investing Heavy Sums into Research and Development of Molecular Biology for Better Revenue Generation
Currently, the PCR market has a diverse portfolio and is enjoying the dominance of manufacturers, namely Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, and QIAGEN. The primary objective of players is to expand the product portfolio and are therefore adopting strategies such as company collaborations, mergers and acquisitions, and others. Besides this, companies are also investing in research and development of molecular biology for attracting high polymerase chain reaction market revenue in the forecast period.
Significant Industry Developments of Polymerase Chain Reaction Market include:
List of Operators in the PCR Market include:
Further Report Findings
Global Polymerase Chain Reaction Market is segmented in the following manner:
Value (USD billion)
By End User